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Abstract
 .The in vitro effects of rapamycin on prolactin PRL -stimulated S6 kinase activity and milk product synthesis were
investigated in cultured mouse mammary tissues. Mouse mammary gland explants were initially incubated for 24 h in M199
media containing 1 mgrml insulin and 10y7 M cortisol. A subsequent treatment of the tissues with 1 mgrml PRL for 12 h
caused a 98% increase in S6 kinase activity in the cytosolic fraction; effects were not observed at earlier times. PRL at or
above 500 ngrml was needed to elicit a maximum stimulation of S6 kinase activity, and this response was specific for
 .lactogenic hormones PRL, hPL, hGH . Rapamycin, an inhibitor of 70 K S6 kinase, was employed to assess the possible
 .physiological role of S6 kinase in the PRL stimulation of milk product formation. Rapamycin 25–100 ngrml impeded, in
a dose-dependent fashion, the PRL stimulation of casein, lipid and lactose synthesis in concert with its inhibition of
cytoplasmic S6 kinase activity. These results suggest a possible role for the activation of 70 K kinase in the signalling
pathway for the PRL regulation of milk product synthesis in the mammary gland. q 1997 Elsevier Science B.V.
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1. Introduction
 .The lactogenic hormone prolactin PRL stimulates
the development of the mammary gland as well as
w xmilk product formation during lactation 1–3 . In
studies designed to determine the molecular mecha-
nism by which PRL functions, PRL was shown to
stimulate the phosphorylation of the 40S ribosomal
protein, S6, which, in part, regulates the rate of
translation and accordingly protein synthesis in Nb2
w xcells 4,5 . Phosphorylation of the S6 protein is cat-
)  .Corresponding author. Fax: q1 313 577 5494.
alyzed by two S6 kinases which are two genetically
 S6K .distinct isoforms, 70K S6 kinase P70 and 90K
 S6K .S6 kinase P90 . When employing the S6 protein
as a substrate, P70S6K is more specific and 15- to
S6K w x30-fold more effective than P90 6–8 . Both S6
kinases are activated by serinerthreonine phosphory-
lation; removal of these groups returns the proteins to
w x S6K S6Ktheir inactive state 9–11 . P70 and P90 are
activated by two distinct pathways. While P90S6K
activation probably occurs primarily via the MAP2K
w x S6Kpathway 11 , P70 is activated via a rapamycin-
sensitive pathway which likely involves PI-3 kinase
w x12 .
Rapamycin, an immunosuppressant, was found to
induce arrest of eukaryotic cell division cycle in G1
0167-4889r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 97 00057-8
( )J. Hang, J.A. RillemarBiochimica et Biophysica Acta 1358 1997 209–214210
w x13 , thus preventing the interleukin-2-induced prolif-
w x w xeration of T-cells 14 . Han et al. 15 reported that
pretreatment of Swiss 3T3 cells with rapamycin
blocks phosphorylation of four of 7 sites on P70S6K
which are phosphorylated upon serum stimulation.
Rapamycin was used in the present studies to deter-
mine whether the PRL stimulation of milk lipid,
casein and lactose synthesis in mouse mammary
glands involves activation of P70S6K.
2. Materials and methods
2.1. Incubation system
 .Midpregnant 10–14 days of pregnancy Swiss–
Webster mice were purchased from Harlan Laborato-
 .  .ries Indianapolis, IN . Ovine PRL NIH-P-S-14 was
a gift from NIH. Other substances were from the
following sources: cortisol from Charles Pfizer New
.  .York, NY ; medium 199 with Earle’s salts M199
 .and Hanks’ balanced salt solution HBSS from Gibco
 .Laboratories Grand Island, NY ; porcine insulin,
penicillin and streptomycin from Eli Lilly Co. Indi-
.anapolis, IN ; rapamycin, p-nitrophenyl phosphate
 .p-NPP , ethylene glycol, tetrasodium pyrophos-
 .phate, DL-dithiothreitol DTT , MOPS, from Sigma
 .Co.; S6 kinase substrate peptides RRRLSSLRA
corresponding to amino acids 231–239 of human 40S
ribosomal protein S6 from Upstate Biotechnology
 . w 32 x  .Lake Placid, NY ; g- P ATP 3000 Cirmmol ,
w 3 x  . w14 x H leucine 53 Cirmmol , C acetate 58
. w 3 x  .Cirmmol and 5,6- H glucose 66.6 Cirmmol ,
 .from NEN Boston, MA . Methods used to culture
w xtissues in our laboratory were described earlier 16 .
Briefly, mice are killed by cervical dislocation, and
the caudal and inguinal pair of mammary glands are
removed aseptically and placed in HBSS. The glands
are cut into pieces weighing 3–5 mg and placed on
siliconized lens paper floating on 6 ml M199 contain-
 .  y7 .ing insulin 1 mgrml and cortisol 10 M in
sterile culture dishes. All incubations are carried out
at 378C in an atmosphere of 95% air–5% CO2
 .volrvol . All explants initially undergo a 24-h incu-
bation in M199 containing insulin and cortisol. Ex-
periments are then begun by adding fresh culture
medium alone or plus PRL. Rapamycin, when used,
was added 1 h before PRL was applied.
2.2. Preparation of tissue extracts for S6 kinase assay
Treated tissues were homogenized ground glass
.homogenizer in 5 ml ice-cold extraction buffer, pH
7.5, containing 20 mM Tris, 15 mM MgCl , 20 mM2
EGTA, 40 mM p-NPP, 1 mM DTT and 0.1 mM
w xPMSF 17 . Homogenates were centrifuged at 1000
=g for 15 min at 48C, after which the supernatant
was centrifuged at 35 000=g for 1 h at 48C. The
resulting supernatant was referred to as the cytosolic
enzyme extract.
2.3. In ˝itro S6 kinase assay
Supernatants were diluted 1:20 in S6 kinase assay
buffer 50 mM Tris, 0.1 mM EGTA, 5% ethylene
glycol, 5 mM DTT, 10 mM MgCl , 0.1% Triton2
. w xX-100 and 0.25 mgrml BSA, pH 7.5 17 . S6 kinase
w xactivity was carried out as previously described 9 ,
except that the reactions were terminated by the
w xaddition of 0.5 vol of 33% TCA 18 . The reaction
mixtures were spotted onto P81 filter papers and
washed with 50 ml of a solution containing 1 mM
Fig. 1. Time-course of PRL on S6 kinase activity. Explants were
incubated for 24 h in culture medium containing insulin 1
.  y7 .mgrml and cortisol 10 M . Time-course was begun by
 .adding fresh culture medium alone or with prolactin 1 mgrml ,
and incubation continued for the times indicated. At the end of
this incubation, explants were collected and S6 kinase activity
was then determined as described in the text. ), ))Significantly
greater than control with P -0.05 and P -0.01, respectively.
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Fig. 2. Dose-response of PRL stimulation on S6 kinase activity.
 .Explants were incubated in medium containing insulin 1 mgrml
 y7 .and cortisol 10 M for 24 h and then incubated in fresh
culture medium alone or with the addition of the indicated
amount of PRL for another 12 h. At the end of incubation,
explants were collected and S6 kinase activity was then deter-
mined. ))Significantly greater than control with P -0.01.
Na P O , 1 mM unlabeled ATP, 100 mM H PO ,4 2 7 3 4
w xand 5% TCA 18 . Radioactivity on the filter papers
was then determined via scintillation counting.
2.4. Assays for casein, lipid and lactose synthesis
w3 x For the casein synthesis assay, H leucine 0.5
.mCirml was added to the culture medium for the
w3 xfinal 2 h of incubation. The amount of H leucine
incorporated into a casein-rich phosphoprotein frac-
w xtion was then determined 19 . For the lipid synthesis
w14 x assay, the tissues were exposed to C acetate 0.2
.mCirml for the final 2 h of incubation. The tissues
were weighed, homogenized in 0.4 ml distilled water
after which the lipids were extracted by the method
w xof Bligh and Dyer 1959 20 . Incorporated radioactiv-
ity was then quantitated. For the lactose synthesis
wassay, the tissues were exposed to 1 mCirml 5,6-
3 xH glucose for the last 2 h of incubation. Lactose was
isolated via thin layer chromatography and the ra-
w xdioactivity in lactose then quantitated 21 .
2.5. Statistical analysis
Statistical comparisons were made with Student’s
t-test when 2 means were compared, or an analysis of
variance followed by Sheffe’s test for multiple com-
parisons. All values represent the mean"S.E. of 4
observations.
 .Fig. 3. Specificity of PRL effect of S6 kinase activity. Explants were incubated for 24 h in culture medium containing insulin 1 mgrml
 y7 .  .and cortisol 10 M , then incubated in fresh culture medium alone control or with PRL, T3, hPL, and hGH for another 12 h. At the
end of this incubation, explants were collected and S6 kinase activity was determined. ))Significantly greater than control with
P-0.01.
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3. Results
PRL stimulates S6 kinase activity in mouse mam-
mary explants in a time- and dose-dependent manner.
 .Fig. 1 shows a time course 0–48 h of PRL-induced
 .activation of S6 kinase. A significant 98% increase
in S6 kinase activity was initially observed after a
 .12-h PRL 1 mgrml treatment, but not at earlier
times. At 16 h, the magnitude of this response was
about 50%, and it persisted for another 8 h. The
response then gradually decreased to basal levels by
48 h. When mammary tissues were treated with
different concentrations of PRL, a dose-dependent
increase in 32P incorporation into S6 protein was
 .observed Fig. 2 . PRL concentrations at 500 ngrml
or above were sufficient to elicit a maximum stimula-
tory response. Other lactogenic hormones including
 .  .hPL 1 mgrml and hGH 1 mgrml also stimulated
 .S6 kinase activity; however, T 1 mgrml was3
 .without effect Fig. 3 .
To determine which of the two S6 kinases is
regulated by PRL, we introduced rapamycin which is
Fig. 4. Dose-response of rapamycin effect on PRL stimulated S6
kinase activity. Explants were incubated for 24 h in culture
 .  y7 .medium containing insulin 1 mgrml and cortisol 10 M .
After preincubation with rapamycin for 1 h, 1 mgrml PRL was
added and incubation was continued for 12 h. S6 kinase activity
was determined as described in the text. ))Significantly greater
than control with P -0.01.
Fig. 5. Dose-response of rapamycin on PRL stimulated casein
synthesis. Explants were incubated for 24 h in culture medium
 .  y7 .containing insulin 1 mgrml and cortisol 10 M . After
preincubation with rapamycin for 1 h, 1 mgrml PRL was added
and incubation was continued for 12 h. Casein synthesis was
determined as described in the text. ), ))Significantly greater
than control with P -0.05 and P -0.01, respectively.
Fig. 6. Dose-response of rapamycin on PRL stimulated lipid
synthesis. Explants were incubated for 24 h in culture medium
 .  y7 .containing insulin 1 mgrml and cortisol 10 M . After
preincubation with rapamycin for 1 h, 1 mgrml PRL was added
and incubation was continued for 12 h. Lipid synthesis was
determined as described in the text. ), ))Significantly greater
than control with P -0.05 and P -0.01, respectively.
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Fig. 7. Dose-response of rapamycin on PRL stimulated lactose
synthesis. Explants were incubated for 24 h in culture medium
 .  y7 .containing insulin 1 mgrml and cortisol 10 M . After
preincubation with rapamycin for 1 h, 1 mgrml PRL was added
and incubation was continued for 12 h. Lactose synthesis was
determined as described in the text. )Significantly greater than
control with P -0.05.
a specific P70S6K inhibitor. Rapamycin at 50 ngrml
completely inhibited the PRL stimulation of S6 ki-
 .nase activity Fig. 4 . At concentrations of 100 ngrml
and above, rapamycin decreased basal S6 kinase
activity as well. Having shown that rapamycin in-
hibits S6 kinase activity in mouse mammary explants,
we next tested the effect of rapamycin on the PRL
stimulation of milk product formation. Figs. 5–7
show the effects of rapamycin on the extent of PRL
w3 xstimulation of H leucine incorporation into casein,
w14 x w3 xC acetate incorporation into lipids and H glucose
incorporation into lactose. In a dose-dependent man-
ner, rapamycin at concentrations of 25–100 ngrml
inhibited the PRL stimulation of lipid, casein and
lactose synthesis, while not affecting the basal rates
of synthesis of lactose or lipids; the basal rate of
synthesis of casein was significantly reduced by ra-
 .pamycin Fig. 5 .
4. Discussion
This study reports for the first time that prolactin
stimulates S6 kinase enzymatic activity in cultured
mouse mammary tissues. This response is first de-
tected 12 h after adding PRL to the tissues. This
delayed effect of PRL is compatible with the delayed
effect of PRL on milk product synthesis which is
initially detected 6–12 h after adding PRL to cultured
w xmammary tissues 1–3 . It is possible that the time
required for PRL to express its effect on milk product
synthesis in cultured mammary tissues is causally
related to the time required for PRL to stimulate S6
kinase activity. The peak effect of PRL on S6 kinase
activity occurs after about 12 h, and the response
abates to control levels by 48 h. In Nb cells, PRL2
w xalso stimulates S6 kinase activity 18 , but the re-
sponse profile is somewhat different. A maximal
effect of PRL on S6 kinase activity in Nb cells2
occurs at 2 h, while the stimulation returns to control
level by 6 h. The differing time-courses for S6 kinase
activation in the two cell types likely relates to the
differing biological responses in the two model sys-
tems, i.e. one is a mitogenic response and the other a
differential response. The responses are similar only
 .in that an extended PRL exposure h is required to
attain a maximum activation of S6 kinase in both
systems.
Many mitogenic agents have been shown to acti-
vate P90S6K by the MAP kinase pathway; this S6
kinase catalyzes the hyperphosphorylation of riboso-
w x S6Kmal protein S6 11,22 . The genetically distinct P70
w xis not a substrate for MAP kinase 23,24 . Rapamycin
is specific in inhibiting P70S6K activation by causing
w x S6Kdephosphorylation of the enzyme 15 . P90 activ-
w xity is unaffected by rapamycin 25,26 .
w xIn earlier studies 1–3 , PRL was reported to stim-
ulate milk lipid, lactose and casein synthesis in cul-
tured mouse mammary tissues. In the present study,
we found that at 25–100 ngrml rapamycin inhibited
 .the PRL stimulation of S6 kinase activity Fig. 4 , as
well as the synthesis of each of the milk products
 .Figs. 5–7 . These data thus suggest the involvement
of P70S6K in the differentiative effects of PRL in the
mammary gland. In addition, since P90S6K tends to
reside in the nucleus due to its amino-terminal exten-
sion which serves as a nuclear localization signal
w x27 , our data derived from the cytosolic fraction
further suggest the specific activation of P70S6K in
the PRL responses. These studies suggest that the
activation of P70S6K may be involved in the sig-
nalling pathway by which PRL stimulates milk prod-
uct synthesis in the mammary gland.
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